Nicolás Isambert
Impact in
- Oncology top 0.5%
- Vascular Tumors and Angiosarcomas
- Pulmonary and Respiratory Medicine top 0.5%
- Sarcoma Diagnosis and Treatment
Papers in
- Oncology 100
- Colorectal Cancer Treatments and Studies 21
- Vascular Tumors and Angiosarcomas 21
- Cancer Immunotherapy and Biomarkers 18
- Cancer Treatment and Pharmacology 17
- HER2/EGFR in Cancer Research 14
-
- Sarcoma Diagnosis and Treatment 54
- Lung Cancer Treatments and Mutations 21
- Co-authors
- Nicolas Penel (69 shared papers)Jean‐Yves Blay (76 shared papers)Rodolfo Lavilla (9 shared papers)Emmanuelle Bompas (60 shared papers)Antoîne Italiano (67 shared papers)Christine Chevreau (40 shared papers)Sophie Piperno‐Neumann (34 shared papers)François Bertucci (50 shared papers)
- Journals
- Journal of Clinical Oncology (55 papers)Annals of Oncology (40 papers)European Journal of Cancer (11 papers)Cancer Research (8 papers)Cancer Chemotherapy and Pharmacology (7 papers)
- Partner nations
- FranceUnited StatesSpain
In The Last Decade
Nicolás Isambert
232 papers receiving 7.1k citations
Nicolás Isambert's Hit Papers
Peers
Comparison fields: 5 of 122
- Oncology 2.5k
- Pulmonary and Respiratory Medicine 2.7k
- Gastroenterology 322
- Rheumatology 798
- Cardiology and Cardiovascular Medicine 857
Countries citing papers authored by Nicolás Isambert
This map shows the geographic impact of Nicolás Isambert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Isambert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Isambert more than expected).
Fields of papers citing papers by Nicolás Isambert
This network shows the impact of papers produced by Nicolás Isambert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Isambert. The network helps show where Nicolás Isambert may publish in the future.
Co-authors
The 25 scholars most cited alongside Nicolás Isambert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 242 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 488 | |
| 2 | 2010 | 394 | |
| 3 | 2008 | 287 | |
| 4 | Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study Hit paper breakdown → | 2018 | 240 |
| 5 | 2015 | 177 | |
| 6 | 2009 | 163 | |
| 7 | 2012 | 157 | |
| 8 | 2012 | 154 | |
| 9 | 2006 | 145 | |
| 10 | 2015 | 140 | |
| 11 | 2011 | 129 | |
| 12 | 2018 | 127 | |
| 13 | 2017 | 126 | |
| 14 | 2013 | 122 | |
| 15 | 2011 | 121 | |
| 16 | 2016 | 119 | |
| 17 | 2008 | 117 | |
| 18 | 2011 | 115 | |
| 19 | 2016 | 108 | |
| 20 | 2011 | 92 |
About Nicolás Isambert
Nicolás Isambert is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Pathology and Forensic Medicine and Gastroenterology, having authored 242 papers that have together received 7.2k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (54 papers), Gastrointestinal Tumor Research and Treatment (22 papers), Colorectal Cancer Treatments and Studies (21 papers), Vascular Tumors and Angiosarcomas (21 papers), Lung Cancer Treatments and Mutations (21 papers), Cancer Immunotherapy and Biomarkers (18 papers), Cancer Treatment and Pharmacology (17 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Oncology (2.5k citations), Pulmonary and Respiratory Medicine (2.7k citations), Gastroenterology (322 citations), Rheumatology (798 citations) and Cardiology and Cardiovascular Medicine (857 citations). Nicolás Isambert has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Nicolas Penel, Jean‐Yves Blay, Rodolfo Lavilla, Emmanuelle Bompas, Antoîne Italiano, Christine Chevreau, Sophie Piperno‐Neumann, François Bertucci, Thierry Constantieux and Isabelle Ray‐Coquard. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Cancer Research and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.